RRD Answers Industry’s Call for Consolidated Supplier Solutions with Specialized Life Sciences Platform

With a growing regulatory-compliant facility footprint and sharpened focus on marketing communications and secondary packaging supply chain, RRD is positioned to drive product commercialization for life sciences companies.

R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, has introduced a comprehensive solution for the commercialization of life sciences products. With a focus on marketing communications and the secondary packaging supply chain, this specialized offering from RRD’s Life Sciences group meets the industry’s growing need for consolidated supplier solutions amid increasing regulatory scrutiny.

“From concept to consumers, our platform for product commercialization makes end-to-end visibility possible, which is something our clients find tremendous value in as they seek to reduce risk, meet inflexible timelines, and alleviate margin pressures,” says Ken Gammon, Senior Vice President, RRD Healthcare Solutions. The following core capabilities and services form the foundation of RRD’s single-source offering:

• Creative execution – a global creative suite of production services
• Marketing communications – industry expertise and production support for all healthcare-professional and consumer-facing communications
• Packaging and labels – structural engineering, design, testing and manufacturing of product packaging and secondary packaging
• Kitting and fulfillment – a globally integrated network to drive resilience, speed to market and increase market share for both indirect and direct product execution

Having supported hundreds of clients in life sciences, RRD has emerged as a trusted industry leader due in part to its organizational commitment to quality management. Heading into 2024, the company will continue this commitment to the highest standards of quality as it increases the number of regulatory-compliant facilities within its global footprint.

“In this era of supplier consolidation, life sciences companies are looking for reliable industry partners who can deliver solutions that promise value, compliance, and resilience across their product’s life cycle,” says John Pecaric, Chief Operating Officer, RRD. “Our investment in cGMP and ISO13485 compliance illustrates our philosophy that patient safety and brand integrity should never be compromised.”

To learn more about RRD’s single-source solution for all commercialization activities related to marketing communications and secondary packaging supply chain management, visit: rrd.com/life-sciences